期刊文献+

稀有放线菌产生抗菌药物的多样性 被引量:3

Diversity of Antibiotics from Rare Actinomycetes
原文传递
导出
摘要 目的对稀有放线菌产生抗菌药物的结构类型和生物活性作一综述,提供有关稀有放线菌研究的借鉴资料。方法查阅近10多年来国内外公开发表的有关稀有放线菌产生抗菌药物的相关文献,对其产生抗菌药物的结构及生物活性进行论述。结果稀有放线菌产生的抗菌药物具有结构多样及活性独特的特点,主要有14种结构类型。结论稀有放线菌是新生物活性物质的重要产生菌,本文为今后稀有放线菌的进一步研究提供了参考。 OBJECTIVE To summarize the structure types and bioactivities of antibiotics from rare streptomyces, and provide reference information for further research. METHODS Based on the over ten years′ research literatures of antibiotics from rare streptomyces domestic and abroad, chemical constituents and bioactivities were reviewed. RESULTS Antibiotics from rare actinomycetes had characteristics of diverse structures and unique bioactivity, constituted mainly by 14 structure types. CONCLUSIONS Rare actinomycetes are important producers for novel bioactive compounds. The review can provide the evidence for the further study on the research of rare streptomyces.
出处 《中国现代应用药学》 CAS CSCD 2013年第12期1373-1384,共12页 Chinese Journal of Modern Applied Pharmacy
关键词 稀有放线菌 抗菌药物结构多样性 生物活性 rare actinomycetes the structural diversities of antibiotics bioactivities
  • 相关文献

参考文献2

二级参考文献36

  • 1李兆龙.一种新的饲料添加剂——那西肽[J].今日科技,1993,13(2):6-7. 被引量:2
  • 2刘云海,李敬,谢委,丁玺,陈雪琴.板蓝根中邻氨基苯甲酸的抗内毒素作用[J].中南药学,2005,3(3):138-141. 被引量:9
  • 3崔征,袁丹,江泽荣,李玉山,殷军,于德泉,李锦和.头结海绵化学成分的研究[J].中国药学杂志,1995,30(9):524-526. 被引量:11
  • 4陈业高,于丽丽,张燕.马蹄香化学成分的分离与鉴定[J].云南化工,2005,32(5):13-16. 被引量:15
  • 5Lazzarini A, Cavaletti L, Toppo G. et al. Rare genera of actinomycetes as potential producers of new antibiotics [J]. Antonie van Leeuwenhoek,2000,78(3-4):399-405.
  • 6Laakso J A.Mocek U M.Dun J V,et al.R176502,a new bafilolide metabolite with potent antioroliferative activity from a noevl Micromonospora species[J].J Antibiot,2003,56(11):909-916.
  • 7Yang S W, Chan T M, Terracciano J, et al. A new anthracycline antibiotic micromonomycin from Micromo-nospora sp. [J]. J Antibiot,2004,57(9):601-604.
  • 8Furumai T, Igarashi Y, Higuchi H, et al. Kosinostatin, a quinocycline antibiotic with antitumor activity from Micromonospora sp. TP-A0468 [J]. J Antibiot, 2002,55 (2):128-133.
  • 9Antal N, Fiedler H P, Stackebrandt E, et al. Retymicin, galtamycin B, saquayamycin Z and ribofuranosyllumichrome, novel secondary metabolites from Micrornonospora sp. Tu 6368 I. Taxonomy, fermentation, isolation and biological activities [J]. J Antibiot,2005,58 (2): 95-102.
  • 10Yeo W H, Yun B S, Kim Y S, et al. GTRI-BB, a new cytotoxic isochromanquinone produced by Micromonospora sp. SA-246 [J]. J Antibiot,2002,55(5):511-515.

共引文献18

同被引文献45

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部